Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-5996
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment ; volume:6 ; number:1 ; day:22 ; month:1 ; year:2014 ; pages:1-6 ; date:12.2014
Diabetology & metabolic syndrome ; 6, Heft 1 (22.1.2014), 1-6, 12.2014
- Creator
-
Miñambres, Inka
Sánchez-Quesada, Jose Luis
Sánchez-Hernández, Joan
Rodríguez, Jose
de Leiva, Alberto
Pérez, Antonio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1758-5996-6-7
- URN
-
urn:nbn:de:101:1-2021083122004676054889
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Miñambres, Inka
- Sánchez-Quesada, Jose Luis
- Sánchez-Hernández, Joan
- Rodríguez, Jose
- de Leiva, Alberto
- Pérez, Antonio
- SpringerLink (Online service)
Other Objects (12)
A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia
Hyperlipidemia : bringing clarity to lipid management
GENetic characteristics and REsponse to lipid-lowering therapy in familial hypercholesterolemia: GENRE-FH study
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy
The association of serum Klotho concentrations with hyperlipidemia prevalence and lipid levels among US adults: a cross-sectional study
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Lipid Lowering Drugs: Present Status and Future Developments
Secondary findings from whole-exome sequencing data in families with familial combined hyperlipidemia (FCHL)
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia
Hyperlipidemia : bringing clarity to lipid management
GENetic characteristics and REsponse to lipid-lowering therapy in familial hypercholesterolemia: GENRE-FH study
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy
The association of serum Klotho concentrations with hyperlipidemia prevalence and lipid levels among US adults: a cross-sectional study
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Lipid Lowering Drugs: Present Status and Future Developments
Secondary findings from whole-exome sequencing data in families with familial combined hyperlipidemia (FCHL)
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia
Hyperlipidemia : bringing clarity to lipid management
GENetic characteristics and REsponse to lipid-lowering therapy in familial hypercholesterolemia: GENRE-FH study
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy
The association of serum Klotho concentrations with hyperlipidemia prevalence and lipid levels among US adults: a cross-sectional study
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Lipid Lowering Drugs: Present Status and Future Developments
Secondary findings from whole-exome sequencing data in families with familial combined hyperlipidemia (FCHL)
Ezetimibe as lipid-lowering therapy for patients receiving HAART